Evommune Inc. (EVMN) vs YD Bio Limited (YDES)

Evommune Inc. and YD Bio Limited are both Biotechnology companies. Evommune Inc. and YD Bio Limited are of similar size ($332.3M and $309.9M).

Metric	EVMN	YDES	Biotechnology median
P/E	n/m	—	7.88
P/S	n/m	—	11.47
P/B	1.10	—	2.52
Price to free cash flow	n/m	—	21.16
EV/EBITDA	n/m	—	0.74
EV/Sales	n/m	—	10.73
Earnings yield	(130.22%)	—	(28.84%)
Free cash flow yield	(24.39%)	—	(23.03%)

Metric	EVMN	YDES	Biotechnology median
Gross margin	—	—	65.16%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(141.99%)	—	(57.72%)
Return on assets	(62.71%)	—	(49.22%)
Return on invested capital	(82.46%)	—	0.00%

Metric	EVMN	YDES	Biotechnology median
Revenue growth (TTM)	—	—	5.64%
EPS growth (last fiscal year)	75.23%	—	—
Revenue growth, 5-year CAGR	—	—	8.40%
Net income growth, 5-year CAGR	—	—	0.00%

Metric	EVMN	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	11.68	—	4.73
Net debt to EBITDA	1.87	—	0.96

Metric	EVMN	YDES	Biotechnology median
Dividend yield	—	—	2.10%
Payout ratio	—	—	0.00

Metric	EVMN	YDES	Biotechnology median
Market cap	309.93m	332.25m	162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack